PATENT SMELL LIKE MONEY: “proven nanoparticle drug delivery system (NDDS).”
Immunotherapy and vaccine treatments for a wide range of diseases
Havin successfully launched its Vilact range of skincare therapies based on LACTOACTIVE®, Vilacto Bio is devoting its full resources to the pre-clinical development of immunotherapy and vaccine treatments for a wide range of diseases. These treatment approaches are based on LACTOACTIVE iTHER®, a new LACTOACTIVE® variant that combines potent immune-system enhancement with a proven nanoparticle drug delivery system (NDDS).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.